Overview

ST-segment Elevation as an AF Endophenotype

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to look for a similarity in people's genes that may help understand which people could benefit from certain drugs for the treatment of atrial fibrillation (AF).

Phase:

N/A

Details

Lead Sponsor:

Vanderbilt University
Vanderbilt University Medical Center

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Procainamide